#antibodies

The CDC recommends that everyone ages 13 to 64 get a routine HIV test at least once.

We got COVID-19 vaccines in record time. Why are HIV vaccines taking so long?

The new prevention approach shows promise, but it isn’t heading to the clinic anytime soon.

Bamlanivimab and etesevimab may be given to people with mild to moderate COVID-19 who are at high risk for progression to severe disease.

More than 95% of people who recovered from COVID-19 had durable immune system memory up to eight months after infection.

Another vaccine, from Novavax, was 89% effective in a U.K. trial, but both were less potent against the South African coronavirus mutation.

The new prevention approach shows promise, but it isn’t heading to the clinic anytime soon.

Long-lived memory immune cells continue to provide protection even after antibody levels drop.

People who have had evidence of a prior infection appear to have some degree of protection against being reinfected with the virus.

Immune cells called T cells helped prevent reinfection and may be especially important if antibody levels are low or decline over time.

Agency grants emergency authorization for antibody cocktail given to President Trump.

Bamlanivimab is now authorized for nonhospitalized people at high risk for progressing to severe COVID-19.

That’s the hope of research funded by a new Campbell Foundation grant.

The treatment reduced coronavirus levels and sped up recovery in a clinical trial.

Herd immunity occurs when enough people are immune to a disease that it is unlikely to spread within a population.

Plasma from recovered patients recently received a controversial FDA emergency use authorization as a potential treatment for COVID-19.